Chapter 1420: Chapter 1065: The Beauty Trap_2 Chapter 1420: Chapter 1065: The Beauty Trap_2 It has been translated into various languages including English, German, Spanish, French, Japanese, Russian, Arabic, and more, with very high translation quality.

Since the papers in medical journals are openly disseminated, the translators are top doctors in the field, and any inaccuracies in the translation are quickly identified and corrected by peers, making the translation increasingly precise as it circulates.

At this time in the United States, in a manor owned by Li Gaoyang, many top tumor experts are gathered to discuss strategies, including Professor Griffin from the Anderson Cancer Center.

“Ladies and gentlemen, in the field of tumor treatment, we have witnessed a significant breakthrough: a new treatment method known as K Virus Therapy. You might have read the paper on it. Although it also involves the term ‘virus’, K Virus Therapy is entirely different from oncolytic virus therapy; the similarity lies only in the name. K Virus is a unique and safe combination of a virus and a ‘K factor’. This virus can infect tumor cells, and the K factor can initiate the apoptosis of these tumor cells. It’s quite miraculous. They can precisely recognize undifferentiated cells and, once recognized, immediately initiate the apoptosis, leading to the death of tumor cells.”

“This method has already shown promising results in clinical trials with patients suffering from osteosarcoma.”

“It can be predicted that in the near future, this method could completely replace traditional treatment methods, becoming a revolutionary new treatment for tumors.”

Professor Griffin, a world-renowned clinical oncologist in tumors, shared his views with a delighted heart.

Professor Burns, the chief scientist in tumor drug development at BG Company, furrowed his brows after hearing Griffin’s speech: “Professor Griffin, please remember the theme of today’s meeting. We need to discuss strategies around this theme.”

Griffin was obviously too pleased; today’s meeting was hosted by BG Company, and all the attending experts had either directly received research funding from BG Company or their institutes, universities, or hospitals had received substantial donations.

The theme of this meeting was–How to deal with the end of traditional treatment–the K Virus Therapy.

“This is not the happy news you described; it is something terrifying. The emergence of the K Virus means that traditional therapies are destined to decline and perish, just like film cameras before digital cameras. Our situation now is just like that of the film cameras back then. You know, we have accumulated countless technologies in the field of traditional treatments, whether drugs, equipment, or various diagnostic technologies, these technologies have helped us build high barriers in the field of tumor diagnosis and treatment. We once thought that by relying on these high barriers, we could maintain our absolute advantage, but now, all our beautiful creations will be brutally shattered, all our efforts, all our accumulations might one day turn to nothing, what does this mean? It means we will no longer have sufficient funds to research new topics, to solve the many problems in human health,” Professor Burns said with an excited and loud voice.

Griffin was very depressed now, as what was clearly a good thing was being portrayed as something demonic.

“Today, we gather here with two purposes: to discuss strategies and to unite in condemning this Chinese professor, demanding that he fully hand over his research data because this new method is a wealth of all humanity, it should be shared, not monopolized by some individual or company.”

Such hypocrisy, such double standards! BG Company itself holds a large amount of technology, which they consider top secret because it can bring them immeasurable wealth.

Yet now they claim that K Virus Therapy should be shared, which is laughable.

Unexpectedly, Professor Burns’ speech received a wave of approval; they were all highly agitated, eager to criticize Professor Yang Ping for his selfishness for not disclosing the details of his experiments in his paper.

—
In Tokyo, Japan, at the headquarters of Fujiwara Corporation.

Fujiwara Wakan is sitting on a sofa, across from him stands his assistant, Sha Gui.

“This is a document sent from Mr. Gaoyang in the United States, please review it personally.”

“Sit down, we’ve talked about not being so formal; we’ve known each other since we were seven, we were classmates in elementary, middle, to university, I wouldn’t be where I am today without your assistance, I’ve told you many times, sit down and let’s talk,” Fujiwara Wakan said gently.

After several family rivalries, he now firmly holds the supreme power of the entire Fujiwara conglomerate, while the previous head, Fujiwara Tani, has completely retired from the foreground.

Fujiwara Wakan browses through the materials sent by the Americans Li Gaoyang: “They want us to make a move, then they sit back and reap the benefits; if successful, they take the fruits, if it fails, the consequences are on us, they have really thought this through.”

“But can we refuse?” Sha Gui sits opposite, well aware that the Americans are not to be trifled with.

“Actually, we can follow their suggestions, but once we achieve the results, we must not just hand them over; we need to keep a firm grip on them,” Fujiwara Wakan said with a smile.

“Is that possible?”

“Why not?”

“The president is right; we can feign compliance. Those Americans are straightforward and lack strategies; we can take advantage of them.”

“If I’m not mistaken, the task of commercializing this technology will be undertaken by a Chinese company called Ruixing, which will grow into a behemoth in the world of biomedicine.”

“Here’s the intel on Ruixing, President!”

“Huang Jiacai? I didn’t expect it to be him.”

“Do you know this Chinese man, President?”

Fujiwara Wakan paused briefly, as if recalling something: “Do you remember when the old president was sick, and my older brother brought a doctor from China to perform the main surgery?”

“I remember, how could I forget? Those few nights were a storm of blood and fury for the Fujiwara family, and it was then that we defeated our enemies and seized control of the Fujiwara family.”

“Yes, Li Gaoyang said that his research results could destroy our foundation in tumor drugs and shake our position in the medical field. The inventor is this doctor, Professor Yang Ping, and Huang Jiacai from Ruixing Medical had been to Japan at that time. I met him once.”

“Oh?”

“That was in the lobby of the ward section at the Affiliated Hospital of the University of Tokyo. I had just visited my uncle and was going home when I ran into him. We only glanced at each other, but I saw a different aura about him, feeling like he was one of my kind. Turns out my intuition was right; he’s now the head of Ruixing. Though currently just a leader of a Chinese medical company, in the future, he will be the leader of a global giant.”

“That’s right, President, you have a good eye for people. Huang Jiacai once had a business conflict with a subsidiary of BG Company, and he almost won perfectly. Now BG Company is preparing to unleash the power of the entire consortium to crush Ruixing, and again, it’s Huang Jiacai who stands on the opposite side.”

“It’s not just the subsidiaries of BG Company; even Li Gaoyang is no match for him. BG Company has already declined.”

“What should we do?”

“Follow the original plan, with Miss Miyuki taking the lead.”

“Using beauty as a strategy?”

“If we can make Yang Ping one of us, it would be the plan with the smallest investment and the largest benefit.”

“But that would sacrifice Miss Miyuki’s happiness.”

“No, you don’t know. Professor Yang Ping is Little Sister Miyuki’s dream lover. If we can succeed, it will be a win-win situation. Even if Miyuki doesn’t like Yang Ping, for the future of the Fujiwara family, she should make this sacrifice. Great men often falter before beautiful women. Didn’t Einstein also fall for a beautiful Soviet spy? Miyuki is beautiful and smart, a top graduate from the Medicinal College of Tokyo University, and has studied under Yang Ping. They have a solid emotional foundation, and a beautiful love story is bound to happen between them.”

“Would Miss Miyuki agree?”

“She certainly will, whether it’s for personal feelings or considering the family’s interest. She’s already declined a marriage arranged by the family. Why? Because she only has Yang Ping in her heart.”